Rationale and design of the real-world Hellenic disease management patterns with everolimus for women with hormone-receptor-positive, human epidermal growth factor ReceptOR-2 negative advanced breast cancer (The MIRROR) study. (March 2017) - Karanikiotis, C.; Kesisis, G.; Xanthakis, I.; Alexopoulos, A.; Barbounis, V.; Panopoulos, C.; Andreadis, C.; Papadimitriou, C.